Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

transcreation

- PMLiVE

Novartis to acquire Tourmaline Bio in a deal worth $1.4bn

Novartis will gain cardiovascular treatment option pacibekitug

- PMLiVE

Resolution Therapeutics appoints Lucy Singah as CFO and Daniel Kennedy as CBO

Both bring over two decades of experience to the company

Child drawing image with crayon

Making the shortlist for patient engagement and communications

Grace Communications has been shortlisted this year in both the PMi Awards and the Creative Floor Awards for an engaging creative campaign, putting patients at the forefront.

Grace Communications

- PMLiVE

Novo Nordisk to cuts 9,000 jobs in an effort to streamline its operations

The transition will help the company meet the rising global demand in the obesity market

- PMLiVE

Inizio appoints Ryan Quigley as new CEO

Ryan was previously COO at Inizio and has worked in the industry for 25 years

- PMLiVE

Inizio appoints Ryan Quigley as CEO

Inizio have appointed Ryan Quigley as Chief Executive Officer, effective 9 September 2025. Paul Taaffe will remain closely involved with the company as an Advisor and board member going forward. ...

Inizio

- PMLiVE

Ready, Set, Rebrand

What does the creative process of a rebrand look like from concept to completion? We asked Creative Director, Garrick Middleton and Senior Creative & Digital Designer, Jordan Ikin just that....

LOVELIVE

- PMLiVE

Lilly and Circle Pharma agree to collaborate on new oral macrocycle therapies

The agreement is part of the Lilly Catalyze360 model, designed to empower early-stage biotechs

- PMLiVE

Emma Bush appointed as CNX Therapeutics’ Vice President, Commercial

Bush has previously held roles at Galderma, GSK and Teva

- PMLiVE

Invivyd working with FDA towards potential Biologics License Application for COVID-19

The company plans head-to-head safety evaluation with COVID-19 vaccine, pending regulatory alignment

- PMLiVE

Adam Raff appointed as Orbital Therapeutics’ Senior Vice President, Clinical Development

Raff will lead Clinical and Regulatory Operations and will be part of the company’s executive leadership team

- PMLiVE

Atlantic currents: the changing tide of health policy in the US and Europe

By Noah Froud

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links